论文部分内容阅读
肝癌是严重危害人类健康的恶性肿瘤之一。我国肝癌的发病率位居全球首位,其死亡率仅次于胃癌位居第二。由于肝癌起病隐匿,发现时往往已属中晚期。肝癌的介入治疗包括血管性介入治疗和非血管性介入治疗,前者包括肝动脉化疗栓塞、经肝动脉栓塞及治疗、肝动脉灌注大剂量化疗药物治疗及经门静脉化疗或化疗栓塞,后者包括氩氦刀、无水瘤内注射、消融、粒子置入等。原发性肝痛的
Liver cancer is one of the malignant tumors that seriously endanger human health. The incidence of liver cancer ranks first in the world, its mortality rate is second only to stomach cancer. Due to the occult onset of liver cancer, it is often found in the late stage. Interventional treatment of liver cancer includes vascular interventional therapy and non-vascular intervention, the former including hepatic arterial chemoembolization, transcatheter arterial embolization and treatment, hepatic arterial infusion of large doses of chemotherapy drugs and chemotherapy through the portal vein or chemoembolization, the latter including argon Hematoma knife, non-tumor intratumoral injection, ablation, particle implantation and so on. Primary liver pain